Find link

language:

Find link is a tool written by Edward Betts.

Longer titles found: Nivolumab/relatlimab (view)

searching for Nivolumab 27 found (121 total)

alternate case: nivolumab

Oligoclonal antibody (1,204 words) [view diff] exact match in snippet view article find links to article

treatment against immune checkpoint currently approved is the cocktail of nivolumab (anti-PD1 antibody) and ipilimumab (anti-CTLA-4 antibody). It is used

Georgina Long (984 words) [view diff] exact match in snippet view article find links to article

Atkinson, Victoria; Lo, Serigne; et al. (2018). "Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised

Plinabulin (504 words) [view diff] exact match in snippet view article find links to article

Oncol 32:5s. "Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer". Nivolumab in Combination

Stomach cancer (7,890 words) [view diff] exact match in snippet view article find links to article

clinical study reported promising results for a combination therapy using Nivolumab and Anlotinib in the treatment of advanced gastric adenocarcinoma (GAC)

Seagen (3,161 words) [view diff] exact match in snippet view article find links to article

Bristol-Myers Squibb to evaluate combination of brentuximab vedotin and nivolumab in hematologic malignancies 18 February: Supplemental Biologics License

Toni Choueiri (1,497 words) [view diff] exact match in snippet view article find links to article

MK-6482 in highly-refractory RCC patients. He also led the cabozantinib+nivolumab phase 3 study (Checkmate 9ER) that showed this regimen to be superior

Vaginal cancer (2,228 words) [view diff] exact match in snippet view article find links to article

Thomas R. J.; Boni, Valentina (2019-11-01). "Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma:

Riluzole (1,489 words) [view diff] exact match in snippet view article find links to article

(BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors". European Journal of Medical Research

Experimental autoimmune encephalomyelitis (2,134 words) [view diff] exact match in snippet view article find links to article

paucisymptomatic form of multiple sclerosis in a patient treated with nivolumab". Neuro Oncol. 18: iv25. doi:10.1093/neuonc/now188.085. PMC 5782583. Höftberger

Hodgkin lymphoma (8,525 words) [view diff] exact match in snippet view article find links to article

recently reviewed. The evidence is very uncertain about the effect of Nivolumab for patients with a Hodgkin's lymphoma e.g. on the overall survival. Increased

Interstitial nephritis (2,303 words) [view diff] exact match in snippet view article find links to article

inhibitors (e.g. sunitinib), checkpoint inhibitors (e.g. ipilimumab, nivolumab, pembrolizumab, atezolizumab) Contrast agent Gadolininum based contrast

Mavorixafor (535 words) [view diff] exact match in snippet view article find links to article

CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy". Investigational New

Glesatinib (191 words) [view diff] exact match in snippet view article find links to article

Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer " at ClinicalTrials.gov "Mirati Therapeutics

Acral lentiginous melanoma (2,383 words) [view diff] exact match in snippet view article find links to article

metastatic, biologic immunotherapy agents like ipilimumab, pembrolizumab, and nivolumab; BRAF inhibitors, such as vemurafenib and dabrafenib; or a MEK inhibitor

Suzanne L. Topalian (813 words) [view diff] exact match in snippet view article find links to article

work with the program led to a landmark publication in 2012 showing that nivolumab (Opdivo) produced dramatic responses in people with advanced melanoma

California Pacific Medical Center (2,401 words) [view diff] exact match in snippet view article find links to article

Minor, MD, and Mohammed Kashani-Sabet, MD, were key to FDA approval of nivolumab—a new breakthrough cancer therapy—for the treatment of melanoma. CPMC

Telisotuzumab vedotin (417 words) [view diff] exact match in snippet view article find links to article

2022). "A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC". JTO Clinical and Research Reports. 3 (1): 100262

Tumor-associated macrophage (2,510 words) [view diff] exact match in snippet view article find links to article

number NCT03158272 for "A Study to of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread" at ClinicalTrials.gov Inman

Troriluzole (364 words) [view diff] exact match in snippet view article find links to article

(BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors". European Journal of Medical Research

Lymphocyte-activation gene 3 (6,133 words) [view diff] exact match in snippet view article find links to article

NCT03704077 for "An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants

Lymphocyte-activation gene 3 (6,133 words) [view diff] exact match in snippet view article find links to article

NCT03704077 for "An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants

Androgen receptor (9,390 words) [view diff] exact match in snippet view article find links to article

1056/NEJMoa1315815. PMC 4201502. PMID 25184630. "Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant

Crystal Mackall (2,787 words) [view diff] exact match in snippet view article find links to article

Berg, Stacey L.; Weigel, Brenda J.; Mackall, Crystal L. (April 2020). "Nivolumab in children and young adults with relapsed or refractory solid tumours

Eftilagimod alpha (2,722 words) [view diff] exact match in snippet view article find links to article

patients refractory to PD-L1 or PD-1 therapies such as pembrolizumab, nivolumab, avelumab) Second-line HNSCC In each of the three indications, a first

Bradley J. Monk (3,247 words) [view diff] exact match in snippet view article find links to article

developing immune therapy in ovarian cancer and studies avelumab and nivolumab alone or in combination. While discussing COVID-19 and ovarian cancer

Guardant Health (2,514 words) [view diff] exact match in snippet view article find links to article

with MSI-High advanced colorectal cancer who may benefit from Opdivo (nivolumab)". In 2021, Guardant Health introduced Guardant Reveal, the first blood-only

Dario Angelo Alberto Vignali (3,517 words) [view diff] exact match in snippet view article find links to article

the efficacy of anti-LAG3 (Relatlimab) in combination with anti-PD1 (Nivolumab) in patients with metastatic melanoma who had not previously received